Mirae Asset Tiger Bio TOP 10 ETF (KRX:364970)
South Korea · Delayed Price · Currency is KRW 7,380.00
-180.00 (-2.38%)
At close: Jun 2, 2026
4.16% (1Y)
| Assets | 328.24B |
| Expense Ratio | 0.40% |
| PE Ratio | 45.13 |
| Dividend (ttm) | 45.00 |
| Dividend Yield | 0.60% |
| Ex-Dividend Date | Apr 29, 2026 |
| Payout Frequency | Annual |
| Payout Ratio | 26.76% |
| 1-Year Return | +4.74% |
| Volume | 2,723,940 |
| Open | 7,500.00 |
| Previous Close | 7,560.00 |
| Day's Range | 7,315.00 - 7,555.00 |
| 52-Week Low | 7,050.00 |
| 52-Week High | 9,765.00 |
| Beta | 0.44 |
| Holdings | 10 |
| Inception Date | Oct 6, 2020 |
About 364970
Formerly known as Mirae Asset Tiger KRX Bio K-New Deal ETF.
Asset Class Equity
Category Health Care
Region Asia Developed
Stock Exchange Korea Stock Exchange
Ticker Symbol 364970
Provider Tiger ETF
Index Tracked KRX Bio K-New Deal Index - KRW - Benchmark TR Gross
Performance
364970 had a total return of 4.74% in the past year, including dividends. Since the fund's inception, the average annual return has been -5.16%.
Top Holdings
101.26% of assets| Name | Symbol | Weight |
|---|---|---|
| ALTEOGEN Inc. | 196170 | 28.28% |
| Celltrion, Inc. | 068270 | 25.73% |
| Samsung Biologics Co.,Ltd. | 207940 | 23.22% |
| Peptron, Inc. | 087010 | 4.69% |
| HLB Co., Ltd. | 028300 | 4.55% |
| Yuhan Corporation | 000100 | 3.87% |
| ABL Bio Inc. | 298380 | 3.74% |
| LigaChem Biosciences Inc. | 141080 | 3.17% |
| Samsung Epis Holdings Co., Ltd. | 0126Z0 | 2.02% |
| SK Biopharmaceuticals Co., Ltd. | 326030 | 1.98% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Apr 29, 2026 | 45.000 KRW | May 6, 2026 |
| Apr 29, 2025 | 10.000 KRW | May 7, 2025 |
| Apr 29, 2024 | 14.000 KRW | May 3, 2024 |
| Apr 27, 2023 | 15.000 KRW | May 3, 2023 |
| Apr 28, 2022 | 5.000 KRW | May 3, 2022 |
| Apr 29, 2021 | 5.000 KRW | May 4, 2021 |